Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOBIDIP: PI Monotherapy vs Bi-therapy with Lamivudine in HIV
NCT01905059Phase 3Completed
- Sponsor
- ANRS
- Start
- Feb 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of lamivudine in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Feb 2014; status: completed.
02
Drugs
lamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01905059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01905059.